AS

Arpit Saini

Active Director Director DIN 10292130
DIN 10292130 First appointment Aug 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value •••• Premium profile

About Arpit Saini

Data last updated:

Arpit Saini is a Director at Cygneev Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Cygneev Pharmaceuticals Private Limited reported revenue of ₹38.7 Lakh (FY 2025).

DIN 10292130
Primary Designation Director
Industry Pharma
First Appointment 24 Aug 2023
Oldest Company Age 3 yrs
Largest company Cygneev Pharmaceuticals Private Limited · ₹38.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Aug 20232023₹38.7 Lakh (FY 2025)Active

Board colleagues of Arpit Saini

NameDINCompanyDesignation
Sonabiti Murmu10292131Cygneev Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Cygneev Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Arpit Saini

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arpit Saini

Arpit Saini currently holds 1 directorship: Cygneev Pharmaceuticals Private Limited (Director, since 24 Aug 2023, revenue ₹38.7 Lakh (FY 2025)).

Arpit Saini was first appointed on 24 Aug 2023 as Director at Cygneev Pharmaceuticals Private Limited.

The current boards of Arpit Saini's companies include Sonabiti Murmu (Cygneev Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available